TrialThe Journal of antimicrobial chemotherapy2020

Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trial.

Hamideh Abbaspour Kasgari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.